Again AS
Again AS
Revolutionary Microfluidics: The Future of Personalized Medicine
🧪 Microfluidics + 🔬 = 💰 & 💉. Discover how personalized medicine can benefit from this powerful combination.
Revolutionizing Lentiviral Vector Production: A Game-Changing Solution?
🧬 Scalability, productivity, and process yield are challenges in lentiviral vector production. Bioprocessing technologies and AI can help improve efficiency. 🚀
Unlocking Advanced Therapy’s Potential with AI: The Key Ingredients
🌍 Advanced therapy manufacturers must have robust hardware and monitoring software in place before benefiting from AI. 🤖📈
Revolutionary Alliance Launches AI-Driven Eye Therapy
👀 Three companies join forces to develop gene therapy for eye diseases, using AI and machine learning algorithms. 🧬👁️🔬
Revolutionary Biomethane Reactor Sold to Danish CCU Specialist
📅 Electrochaea GmbH has sold a BioCat bioreactor to Danish CCU specialist Again AS. 👥 Again AS uses CO2-fixing archaea to manufacture carbon-negative chemicals at an industrial scale. 💰 Electrochaea sold the bioreactor to Again AS, enriching its R&D work. ♻️ Electrochaea sets a new industry standard for resource efficiency and adaptive bioreactor technology. ⚡️ Electrochaea's biotechnology produces CO2-neutral synthetic methane as a fossil-free alternative for LNG.
